Hyperphosphoremia is common in patients with chronic kidney disease and is an important risk factor in this patient population. Phosphate binding drugs are a key therapeutic strategy to reduce phosphoremia levels, although they have significant side effects especially in the gastrointestinal tract, such as gastritis, diarrhoea and constipation. We report the case of a haemodialysis-dependent patient suffering from chronic kidney disease stage V KDIGO secondary to polycystic autosomal dominant disease; treated with phosphate binders, the case was complicated by the appearance of diverticulosis, evolved into acute diverticulitis.
Keywords: acute diverticulitis; chronic kidney disease; diverticulosis; hyperphosphoremia; phosphate binding drugs; polycystic autosomal dominant disease.
Copyright by Società Italiana di Nefrologia SIN, Rome, Italy.